Walgreen Co. has agreed to buy assets of BioScrip's specialty and mail service pharmacy businesses for $225 million.
In the deal, Walgreens is set to acquire BioScrip's network of 30 specialty pharmacy locations in 16 states and Washington, D.C., which primarily serves HIV, cancer and transplant patients. The nation's largest drugstore operator also will acquire certain assets of BioScrip's centralized specialty pharmacy business and traditional mail service pharmacy business that dispenses prescriptions for, among others, drugstore.com, which was acquired by Walgreens in June 2011.
The acquisition "creates a strong network of support for our core drugstore business to provide specialty pharmacy solutions to our patients," Walgreens President and CEO Greg Wasson said in a statement.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
